Part 1. Summary
Part 2. Introduction
· Study period
· Geographical scope
· Market segmentation
Part 3. Emerging therapeutics for hematological malignancies market overview
Part 4. Market breakdown by type
· CAR T-cell therapies
· Monoclonal antibodies
Part 5. Market breakdown by indication
· Leukemia
· Lymphoma
· Multiple myeloma
Part 6. Market breakdown by region
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
Part 7. Key companies
· AbbVie Inc.
· Amgen Inc.
· Bristol-Myers Squibb Company (BMS)
· F. Hoffmann-La Roche AG
· Gilead Sciences, Inc.
· GlaxoSmithKline plc
· Immune-Onc Therapeutics, Inc.
· Johnson & Johnson
· Merck & Co., Inc.
· Novartis AG
· Pfizer Inc.
· Sanofi S.A.
· Takeda Pharmaceutical Company Limited
Part 8. Methodology